beta
Trial Radar AI

Showing clinical trials for Diabetes Mellitus, Type 2.

I can help you find nearby clinical trials and understand health conditions and treatments.
96 Results
Top 50 Showing
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Condition
Diabetes Mellitus, Type 2
×
 
Study Type
Interventional
×
 
Intervention
GLP-1
×
 
Study Title
Status
GLP-1 and Hypoglycemia NCT01858896
Active, not recruiting
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes (GLOW) NCT07428746
Not yet recruiting
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Active, not recruiting
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM NCT06256419
Recruiting
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM (STABLE-GLP1) NCT07314684
Recruiting
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs (ICDDTKZ26) NCT07303556
Active, not recruiting
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion NCT07398300
Recruiting
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD) NCT05390892
Recruiting
A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2) NCT05984238
Active, not recruiting
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control (MESSAGE) NCT07244003
Recruiting
Endoscopic Band Ligation for Type 2 Diabetes Mellitus (ENDOBAND-DM) NCT07117721
Not yet recruiting
Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk (SIPPA-QH_HHC-2) NCT07032311
Not yet recruiting
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (VESPER-2) NCT06897202
Active, not recruiting
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. (EPHIC-DIA2) NCT06851962
Active, not recruiting
Autologous SVF Therapy for Type 2 Diabetes (LASER-DM2 Tria) NCT07487467
Recruiting
CGM Use in Adults With Type 2 Diabetes on Basal Insulin NCT05944432
Active, not recruiting
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes (DECLARED-CT) NCT06715514
Recruiting
Surgical or Medical Treatment (ST2OMP) NCT04128995
Active, not recruiting
Gut Hormones and Roux en Y Gastric Bypass NCT01945840
Recruiting
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh NCT06449235
Not yet recruiting
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents NCT07307235
Not yet recruiting
Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use (PERIODIC-CGM) NCT07336329
Recruiting
Effects on Remission of Type 2 Diabetes Mellitus Following Gastric Bypass Alone vs Gastric Bypass Combined With Truncal Vagotomy (VagusSx) NCT07278115
Not yet recruiting
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis (SEMAPSO) NCT07401992
Recruiting
The Poor Responders Study NCT05404061
Recruiting
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes NCT06976619
Recruiting
iGlarLixi CGM Study in Chinese T2D Individuals After OADs (China Soli-CGM) NCT06671587
Recruiting
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284
Recruiting
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants NCT06737042
Not yet recruiting
Rebalancing the Fat Content of the Heart and Muscles (Re-CHARM) NCT07065383
Not yet recruiting
Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist (ARAY) NCT06851858
Active, not recruiting
A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes NCT07195994
Recruiting
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes NCT06825182
Recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy NCT07502508
Recruiting
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study) NCT07083154
Recruiting
A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus NCT07055386
Active, not recruiting
Effects of VLCKD in Metabolic Syndrome (KETO-MI) NCT05275608
Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both (REIMAGINE 5) NCT06534411
Active, not recruiting
Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention NCT06682351
Not yet recruiting
A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus NCT06716424
Active, not recruiting
The Medically Reproducing Bariatric Surgery (MRB) II Study NCT06363747
Active, not recruiting
Genetics of Response to Canagliflozin NCT02891954
Active, not recruiting
A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity NCT07438444
Not yet recruiting
A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus NCT07299084
Recruiting
Normal-weight Diabetes: Adipocyte-directed Therapy with Pioglitazone or Tirzepatide NCT06657209
Not yet recruiting
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients (HALLMARK) NCT05938712
Recruiting
HbA1c Variability in Type II Diabetes NCT02879409
Active, not recruiting
Pharmacogenetics of Response to GLP1R Agonists (PORT) NCT05071898
Recruiting
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis (GUARD-1) NCT07017270
Not yet recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) NCT07104383
Recruiting